Standout Papers

Humoral immune response to COVID-19 mRNA vaccine in patients with multiple sclerosis treated with high-efficacy d... 2021 2026 2022 2024232
  1. Humoral immune response to COVID-19 mRNA vaccine in patients with multiple sclerosis treated with high-efficacy disease-modifying therapies (2021)
    Anat Achiron, Mathilda Mandel et al. Therapeutic Advances in Neurological Disorders

Immediate Impact

1 by Nobel laureates 2 from Science/Nature 63 standout
Sub-graph 1 of 23

Citing Papers

mRNA vaccines for infectious diseases — advances, challenges and opportunities
2024 Standout
AGILE platform: a deep learning powered approach to accelerate LNP development for mRNA delivery
2024 Standout
2 intermediate papers

Works of Mark Dolev being referenced

Humoral immune response to COVID-19 mRNA vaccine in patients with multiple sclerosis treated with high-efficacy disease-modifying therapies
2021 Standout
COVID-19 vaccination in patients with multiple sclerosis: What we have learnt by February 2021
2021

Author Peers

Author Last Decade Papers Cites
Mark Dolev 1000 433 428 50 1.4k
David Magalashvili 785 377 428 46 1.1k
Kathleen Costello 1071 407 233 43 1.5k
Shay Menascu 749 354 452 72 1.5k
Bardia Nourbakhsh 835 346 101 56 1.4k
Robert Hoepner 522 314 170 93 1.1k
Romain Deschamps 771 634 272 73 1.3k
Simonetta Galgani 537 232 558 45 1.5k
Dieter Pöhlau 704 364 71 49 1.2k
Shlomo Flechter 594 317 421 38 997
Wallace Brownlee 1047 481 95 61 1.4k

All Works

Loading papers...

Rankless by CCL
2026